A case of subclinical immune checkpoint inhibitor-associated myocarditis in non-small cell lung cancer

Abstract Background Immune checkpoint inhibitors (ICIs) have been widely used in the treatment of cancer. Moreover, immune-related adverse events (irAEs) have become a new clinical challenge. ICI-associated myocarditis is a rare but fatal condition among diverse organ injuries, and early recognition...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yue Hu, Cuixia Liu, Shaojun Jin, Zihan Yi, Chao Wang, Xiaohong Pan, Huaqiong Huang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-04-01
coleção:	BMC Pulmonary Medicine
Assuntos:	Immune checkpoint inhibitors (ICIs) Immune-related adverse events (irAEs) Myocarditis Sintilimab Lung cancer
Acesso em linha:	https://doi.org/10.1186/s12890-023-02417-4
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!